Related by context. Frequent words. (Click for all words.) 69 LY# [003] 69 angiogenesis inhibitor 68 Bortezomib 68 HuMax CD# 68 BAY #-# 67 placebo controlled clinical 67 Desmoteplase 67 Laquinimod 66 LY# [002] 66 Bevacizumab 66 tanespimycin 66 CA4P 66 methylnaltrexone 66 temsirolimus 65 ocrelizumab 65 Leukine 65 double blinded placebo 65 receptor antagonists 65 Azedra 65 Torisel 65 Asentar 65 intravenously administered 65 Phase 2a trial 65 decitabine 65 PEG Interferon lambda 65 BMS # 65 aflibercept 65 abiraterone 65 ELND# 65 administered subcutaneously 65 exon skipping 64 axitinib 64 6R BH4 64 SCH # 64 orally bioavailable 64 Synavive 64 Amigal 64 SRT# [003] 64 CR# vcMMAE 64 RG# [001] 64 anticancer agent 64 Phenoptin 64 interferon alfa 64 phase IIb 64 cardiac toxicity 64 thymalfasin 64 Sorafenib 64 relapsed multiple myeloma 64 Ostarine 64 Combination therapy 63 rHuPH# 63 idiopathic pulmonary fibrosis IPF 63 VEGF Trap 63 nab paclitaxel 63 integrase inhibitor 63 valopicitabine 63 tipranavir 63 teduglutide 63 glufosfamide 63 pramlintide 63 PLX# 63 Pivotal Phase 63 immunomodulator 63 Serdaxin 63 tezampanel 63 Phase IIa trial 63 HGS ETR1 63 Phase 1b trial 63 castration resistant prostate cancer 63 IMC A# 63 Elesclomol 63 Revimmune 62 antisense drug 62 PXD# 62 Pivotal Phase III 62 receptor agonists 62 tyrosine kinase inhibitor 62 Phase Ib 62 phase IIa 62 rNAPc2 62 dose limiting toxicities 62 receptor antagonist 62 glatiramer acetate 62 HER2 positive metastatic breast 62 riluzole 62 humanized anti 62 reperfusion injury 62 muraglitazar 62 DAVANAT 62 relapsing remitting multiple sclerosis 62 tocilizumab 62 biologic therapy 62 dasatinib 62 limiting toxicity 62 TELCYTA 62 NNRTIs 62 CoFactor 62 darapladib 62 Phase 2b trial 62 Erlotinib 62 CGEN #